Selim Giray, the recently appointed VP and general manager of GSK Turkey, provides insights into the company’s eye-catching footprint and commitment to Turkey, his ambition to integrate into the market’s Top Four ranking in the coming years, as well as his aspirations to see the industry and the government work closer together on moving the ecosystem’s agenda beyond the objectives of Vision 2023.
Eight months into the job, how would you assess GSK’s competitive advantages on the Turkish market?
“Our common objective is to ensure that everyone in Turkey has access to the best treatments that are available globally."
